CDK8 and prostate carcinoma: 30 Of note, the steady state growth of ovarian cancer cells in vitro was only slightly affected by the selective CDK8/19 inhibitor SNX631 51 as has also been observed in most other cancers, except for a subset of leukemias, and moderate responses in certain breast, colon, and prostate cancers.